EUVIMEDEUVIMED entdecken
Übersichtsarbeit

3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application

Francisco Branco, Joana Cunha, Maria Mendes, João J Sousa, Carla Vitorino iD

Advanced Materials · 2025

DOI: 10.1002/adma.202501994 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, 2025. Verfasst von Francisco Branco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, Coimbra, 3000-548, Portugal. Hauptthemen laut MEDLINE: Glioblastoma, Bioprinting, Printing, Three-Dimensional, Brain Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 271 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia, Coimbra Chemistry Centre, Santander Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional in vitro models fail to accurately mimic the tumor in vivo characteristics, being appointed as one of the causes of clinical attrition rate. Recent advances in 3D culture techniques, replicating essential physical and biochemical cues such as cell–cell and cell–extracellular matrix interactions, have led to the development of more realistic tumor models. Bioprinting has emerged to advance the creation of 3D in vitro models, providing enhanced flexibility, scalability, and reproducibility. This is crucial for the development of more effective drug treatments, and glioblastoma (GBM) is no exception. GBM, the most common and deadly brain cancer, remains a major challenge, with a median survival of only 15 months post‐diagnosis. This review highlights the key components needed for 3D bioprinted GBM models. It encompasses an analysis of natural and synthetic biomaterials, along with crosslinking methods to improve structural integrity. Also, it critically evaluates current 3D bioprinted GBM models and their integration into GBM‐on‐a‐chip platforms, which hold noteworthy potential for drug screening and personalized therapies. A versatile development framework grounded on Quality‐by‐Design principles is proposed to guide the design of bioprinting models. Future perspectives, including 4D bioprinting and machine learning approaches, are discussed, along with the current gaps to advance the field further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBioprintingPrinting, Three-DimensionalBrain NeoplasmsTissue ScaffoldsHumansAnimals

Stichwörter der Autor:innen

3D bioprintingbiomaterialsglioblastomain vitro modelsorgan‐on‐a‐chipquality‐by‐design

Autor:innen und Institutionen

  • Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, Coimbra, 3000-548, Portugal.
  • Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Faculty of Sciences and Technology, University of Coimbra, Coimbra, 3004-535, Portugal.

ORCID-Profile: Carla Vitorino

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Coimbra Chemistry Centre
  • Santander Universities

Zitieren

APA

Branco, F., Cunha, J., Mendes, M., Sousa, J. J., & Vitorino, C. (2025). 3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application. Advanced Materials. https://doi.org/10.1002/adma.202501994

Vancouver

Branco F, Cunha J, Mendes M, Sousa JJ, Vitorino C. 3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application. Advanced Materials. 2025. doi:10.1002/adma.202501994

BibTeX
@article{Branco2025,
  author = {Branco, Francisco and Cunha, Joana and Mendes, Maria and Sousa, João J and Vitorino, Carla},
  title = {3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202501994}
}
Kostenlos starten →